DIA
AZN icon

Dana Investment Advisors’s AstraZeneca AZN Stock Holding History

Dana Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,311
Closed -$204K – 534
2024
Q2 		$204K Buy
+1,311
New +$197K 0.01% 514
2024
Q1 		– Sell
-2,687
Closed -$362K – 528
2023
Q4 		$362K Sell
2,687
-2,767
-51% -$360K 0.02% 358
2023
Q3 		$739K Buy
5,454
+1,663
+44% +$227K 0.04% 270
2023
Q2 		$543K Buy
+3,791
New +$558K 0.03% 304

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dana Investment Advisors's AZN Position: Q3 2024 in Review

Dana Investment Advisors sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 1,311 shares — an estimated $204K sold.

Dana Investment Advisors first reported a position in AZN in Q2 2023 and held it in 4 quarters. The position peaked at $739K in Q3 2023. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • Dana Investment Advisors reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • Dana Investment Advisors sold 1,311 AstraZeneca shares in Q3 2024, an estimated $204K.
  • Dana Investment Advisors first reported a position in AstraZeneca in Q2 2023 and held it in 4 quarters.
  • Dana Investment Advisors's AstraZeneca position peaked at $739K in Q3 2023.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Dana Investment Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.